With more patents and exclusivity protections expiring and generics becoming more and more present in the larger therapeutic areas, can ‘Big Pharma’ still hope for some growth because of changing demographics, scientific progresses and the development of BRIC+TKM economies? What threats is the pharmaceutical industry facing globally? Our panel of well-known academics, top international management consultants and thought leaders will share their views on how pharma companies are adapting to the new realities in the pharmaceutical industry

will analyse the current regulatory environment, and government initiatives aimed at stimulating market growth and achieving better healthcare provision

How changes to the competitive and regulatory landscape are influencing companies’ strategies for capturing market share and the future of business organisations in pharma? This panel will bring together CEOs of the leading international and domestic pharmaceutical companies who will share their perspectives on the major short- and long-term concerns and discuss the factors that are facilitating the industry’s growth in today’s cost-centric environment

featuring trusted sector experts, who will present a detailed statistical review of the key market segments, therapy areas, products and companies, as well as evaluating the key drivers and barriers to future market development

Is it possible to find a united, industry-led, long-term solution for serving public health?

This panel will bring together niche players in high-end specialised segments, Big Pharmas that are serving the mass market, as well as top generics producers and the leading local players who will assess regulatory, political and budget constraints, and their impact on the way that medicines are approved and paid for

Listen to international pharmaceutical experts from several countries, as they speak about cost-containment and other pricing related measures; reimbursement procedures and health technology assessments that are employed worldwide

Get an overview of the development of the distribution and retail sectors in Russia and Europe and hear from the sector’s major players on their future strategies. This extended session will also offer a special focus discussion on regional retail, featuring co-owners of the most dynamic regional retail chains, who will assess the competitive landscape for regional pharmaceutical retail, and analyse the challenges that domestic retailers face when entering new regions and competing with established players

on 1) Developing Trademark and Patent Litigation Strategy, 2)  Round Table on HR , 3) Pharmaceutical Manufacturing and Quality Standards in Russia, 4) Pharma Partnering

Developing a high-quality, customer-facing strategy by better understanding  ‘prescriber-payer-patient’ dynamics, Developing marketing channels and touch points, Integrating ‘e’ into the sales force mix